Evidence map›Paper›PMID 26739056›Full record

ArticleJournal of virology2016

Prolactin Regulatory Element Binding Protein Is Involved in Hepatitis C Virus Replication by Interaction with NS4B.

Lingbao Kong, Akira Fujimoto, Mariko Nakamura, Haruyo Aoyagi, Mami Matsuda, Koichi Watashi, Ryosuke Suzuki, Minetaro Arita, Satoshi Yamagoe, Naoshi Dohmae and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. The crucial role of prolactin-lactogenic hormone in Covid-19.Molecular and cellular biochemistry · 2022
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Lingbao KongDepartment of Virology II, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Akira FujimotoDepartment of Virology II, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Mariko NakamuraDepartment of Virology II, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Haruyo AoyagiDepartment of Virology II, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Mami MatsudaDepartment of Virology II, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Koichi WatashiDepartment of Virology II, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Ryosuke SuzukiDepartment of Virology II, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Minetaro AritaDepartment of Virology II, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Satoshi YamagoeDepartment of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Naoshi DohmaeRIKEN Center for Sustainable Resource Science, Saitama, Japan.
Takehiro SuzukiRIKEN Center for Sustainable Resource Science, Saitama, Japan.
Yuriko SakamakiResearch Center for Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
Shizuko IchinoseResearch Center for Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
Tetsuro SuzukiDepartment of Infectious Diseases, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Takaji WakitaDepartment of Virology II, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Hideki AizakiDepartment of Virology II, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan aizaki@nih.go.jp.
National Institute of Infectious Diseases · JPHamamatsu University School of Medicine · JPTokyo Medical and Dental University · JPRIKEN Center for Sustainable Resource Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledIt has been proposed that the hepatitis C virus (HCV) NS4B protein triggers the membranous HCV replication compartment, but the underlying molecular mechanism is not fully understood. Here, we screened for NS4B-associated membrane proteins by tandem affinity purification and proteome analysis and identified 202 host proteins. Subsequent screening of replicon cells with small interfering RNA identified prolactin regulatory element binding (PREB) to be a novel HCV host cofactor. The interaction between PREB and NS4B was confirmed by immunoprecipitation, immunofluorescence, and proximity ligation assays. PREB colocalized with double-stranded RNA and the newly synthesized HCV RNA labeled with bromouridine triphosphate in HCV replicon cells. Furthermore, PREB shifted to detergent-resistant membranes (DRMs), where HCV replication complexes reside, in the presence of NS4B expression in Huh7 cells. However, a PREB mutant lacking the NS4B-binding region (PREBd3) could not colocalize with double-stranded RNA and did not shift to the DRM in the presence of NS4B. These results indicate that PREB locates at the HCV replication complex by interacting with NS4B. PREB silencing inhibited the formation of the membranous HCV replication compartment and increased the protease and nuclease sensitivity of HCV replicase proteins and RNA in DRMs, respectively. Collectively, these data indicate that PREB promotes HCV RNA replication by participating in the formation of the membranous replication compartment and by maintaining its proper structure by interacting with NS4B. Furthermore, PREB was induced by HCV infection in vitro and in vivo. Our findings provide new insights into HCV host cofactors. IMPORTANCE: The hepatitis C virus (HCV) protein NS4B can induce alteration of the endoplasmic reticulum and the formation of a membranous web structure, which provides a platform for the HCV replication complex. The molecular mechanism by which NS4B induces the membranous HCV replication compartment is not understood. We screened for NS4B-associated membrane proteins by tandem affinity purification and proteome analysis, followed by screening with small interfering RNA. We identified prolactin regulatory element binding (PREB) to be a novel HCV host cofactor. PREB is induced by HCV infection and recruited into the replication complex by interaction with NS4B. Recruited PREB promotes HCV RNA replication by participating in the formation of the membranous HCV replication compartment. To our knowledge, the effect of NS4B-binding protein on the formation of the membranous HCV replication compartment is newly described in this report. Our findings are expected to provide new insights into HCV host cofactors.

Indexed as

Host-Pathogen InteractionsVirus ReplicationCell LineDNA-Binding ProteinsGuanine Nucleotide Exchange FactorsHepacivirusHepatocytesHumansProtein Interaction MappingProteomicsTranscription FactorsViral Nonstructural ProteinsDNA-Binding ProteinsGuanine Nucleotide Exchange FactorsNS4B protein, flavivirusPREB protein, humanTranscription FactorsViral Nonstructural Proteins

Identifiers

PMID26739056
PMCPMC4810664
OpenAlexW2284821093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.